A 2016 trial of injectable male contraceptive was suspended after determining that the risks to men’s health outweighed the benefits. What brought researchers to that conclusion? Out of 320 men, 20 said they couldn’t tolerate the side effects, which included pain at the injection site, acne, and depression. Yes, based on 20 men saying they were uncomfortable with these symptoms, researchers discontinued the trial despite it being 96 percent effective. For the record, in early birth control trials in women, 15 percent of women had side effects and three women died . . . without investigation.
